Pricing Log in Create free account
Saturday 17 October 2026 Export LLY’s income statement to Excel — free account

Eli Lilly and Company

LLY Healthcare Drug Manufacturers General

Eli Lilly and Company’s revenue for fiscal 2025 (year ended December 2025) was $65.2 billion, up 44.7% from fiscal 2024. In the quarter to June 2026, revenue grew 47.7%, EPS grew 26.2%, free cash flow grew 458.1% and total debt rose 37.6%, each against the same quarter a year earlier. Member of the S&P 500; dividend growth for twenty-five consecutive years, revenue growth for five.

1,257.03 5.42 +0.43%
Market cap
$1.18T
P/E
42.2×
Fwd P/E
33.1×
Dividend yield
0.53%
F-score
7/9
Altman Z
8.61
Beneish M
−1.91
Dividend safety
86/100
Overview Business Profile Financial Analysis Income Statement Balance Sheet Cash Flow Metrics & Ratios Filings 10-Q 10-K

Eli Lilly and Company (LLY) P/S ratio

Alert me on P/S ratio

As of 16 October 2026, Eli Lilly and Company (LLY) trades at a P/S ratio of 14.1×. Over the past ten years it has ranged from 3.3× (December 2016) to 22.8× (June 2024); the current reading is higher than 81% of that period. That is above the Drug Manufacturers General industry median of 3.4× and above the Healthcare sector median of 3.4×.

P/S ratio, daily

Embed this chart

Annual newest first

Period P/S ratio Change
FY2025 14.8× (4.15%)
FY2024 15.4× (1.20%)
FY2023 15.6× 35.48%
FY2022 11.5× 30.35%
FY2021 8.8× 41.66%
FY2020 6.2× 13.90%
FY2019 5.5× (0.92%)
FY2018 5.5× 24.06%
FY2017 4.5× 19.89%
FY2016 3.7× (17.02%)

Quarterly newest first

Period P/S ratio Change
Jun 2026 13.4× 17.99%
Mar 2026 11.4× (23.03%)
Dec 2025 14.8× 28.46%
Sep 2025 11.5× (12.37%)
42 more quarters

Against its own ten years

Low 3.3× High 22.8×
Ten-year median 6.4×
Current reading's percentile 80

P/S ratio against peers

Company P/S ratio
PFE Pfizer Inc. compare 2.6×
AZN AstraZeneca PLC compare 4.2×
NVS Novartis AG compare 5.1×
MRK Merck & Co., Inc. compare 5.4×
AMGN Amgen Inc. compare 6.1×
JNJ Johnson & Johnson compare 6.2×
GILD Gilead Sciences, Inc. compare 6.4×
ABBV AbbVie Inc. compare 7.8×
LLY Eli Lilly and Company 14.1×
Drug Manufacturers General industry median 3.4×
Healthcare sector median 3.4×
Market median 1.9×

What P/S ratio is

Price to Sales Ratio shows how much investors pay for each dollar of a company’s annual sales, whether or not it is profitable.

(Stock Price × Shares (Basic, Weighted) (latest quarter)) ÷ Revenue (TTM)

The full definition of P/S ratio →

More on LLY